Cargando…
Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis
Sodium-glucose cotransporter 2 inhibitor (SGLT2i) potentially decrease all-cause and cardiovascular death, however, associations with non-cardiovascular death remain unclear. Therefore, we investigated SGLT2i associations with death and the cause of death. We used the Taiwanese National Health Insti...
Autores principales: | Chung, Mu-Chi, Hsu, Hui-Tsung, Chang, Chao-Hsiang, Hung, Peir-Haur, Hsiao, Po-Jen, Wu, Laing-You, Wu, Ming-Ju, Shieh, Jeng-Jer, Chung, Chi-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203810/ https://www.ncbi.nlm.nih.gov/pubmed/35710921 http://dx.doi.org/10.1038/s41598-022-13760-7 |
Ejemplares similares
-
Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2021) -
Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2023) -
Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2020) -
Long-term exposure to air pollutants and increased risk of chronic kidney disease in a community-based population using a fuzzy logic inference model
por: Lin, Hsueh-Chun, et al.
Publicado: (2022) -
The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
por: Li, Yan-Rong, et al.
Publicado: (2021)